Fingerprint
Dive into the research topics of 'Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: A phase I/II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: A phase I/II trial
Daniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad, Daniel A. Laheru, Lon S. Smith, Tina E. Wood, Ronald L. Korn, Neil Desai, Vuong Trieu, Jose L. Iglesias, Hui Zhang, Patrick Soon-Shiong, Tao Shi, N. V. Rajeshkumar, Anirban Maitra, Manuel Hidalgo
Research output: Contribution to journal › Article › peer-review
772
Scopus
citations